US judge urges Lilly to settle Zyprexa claims
This article was originally published in Scrip
Executive Summary
A federal judge in New York is urging Lillyto settle a putative class action lawsuit filed by insurance companies, labour unions and others who claim the company improperly marketed and made false claims about its top-selling product Zyprexa (olanzapine), causing Zyprexa "to command a higher price than it would have had the truth been known to those who prescribed, bought or paid for the product".